MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-2,082 Cr | ₹-1,054 Cr | ₹-1,369 Cr | ₹-1,222 Cr | ₹-439 Cr |
What is the latest Cash Flow from Investing Activities ratio of MANKIND PHARMA ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-2,082 Cr |
Mar2023 | ₹-1,054 Cr |
Mar2022 | ₹-1,369 Cr |
Mar2021 | ₹-1,222 Cr |
Mar2020 | ₹-439 Cr |
How is Cash Flow from Investing Activities of MANKIND PHARMA Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-2,082 Cr | Negative | |
Mar2023 | ₹-1,054 Cr | Negative | |
Mar2022 | ₹-1,369 Cr | Negative | |
Mar2021 | ₹-1,222 Cr | Negative | |
Mar2020 | ₹-439 Cr | - |
Compare Cash Flow from Investing Activities of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹102,282.7 Cr | 0.9% | -3.4% | 37% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,518.0 Cr | -0.1% | -6.3% | 49.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,636.0 Cr | 3.5% | 0.9% | 66.2% | Stock Analytics | |
CIPLA | ₹118,368.0 Cr | -2.6% | -3.8% | 19.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,671.4 Cr | -4.1% | -10.8% | 9.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,013.6 Cr | -2% | -6.1% | 49.9% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 0.9% |
-3.4% |
37% |
SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses